Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial

BACKGROUND: Remission is the primary objective of treating juvenile idiopathic arthritis (JIA). It is still debatable whether early intensive treatment is superior in terms of earlier achievement of remission. The aim of this study was to evaluate the effectiveness of early etanercept+methotrexate (...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexeeva, Ekaterina, Horneff, Gerd, Dvoryakovskaya, Tatyana, Denisova, Rina, Nikishina, Irina, Zholobova, Elena, Malievskiy, Viktor, Santalova, Galina, Stadler, Elena, Balykova, Larisa, Spivakovskiy, Yuriy, Kriulin, Ivan, Alshevskaya, Alina, Moskalev, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788754/
https://www.ncbi.nlm.nih.gov/pubmed/33407590
http://dx.doi.org/10.1186/s12969-020-00488-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788754/
https://www.ncbi.nlm.nih.gov/pubmed/33407590
http://dx.doi.org/10.1186/s12969-020-00488-9

Ejemplares similares